Betts G - Search Results

1

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.

White AD, Sibley L, Dennis MJ, Gooch K, Betts G, Edwards N, Reyes-Sandoval A, Carroll MW, Williams A, Marsh PD, McShane H, Sharpe SA. White AD, et al. Among authors: betts g. Clin Vaccine Immunol. 2013 May;20(5):663-72. doi: 10.1128/CVI.00690-12. Epub 2013 Feb 27. Clin Vaccine Immunol. 2013. PMID: 23446219 Free PMC article.

2

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A.

Stylianou E, Griffiths KL, Poyntz HC, Harrington-Kandt R, Dicks MD, Stockdale L, Betts G, McShane H. Stylianou E, et al. Among authors: betts g. Vaccine. 2015 Nov 27;33(48):6800-8. doi: 10.1016/j.vaccine.2015.10.017. Epub 2015 Oct 23. Vaccine. 2015. PMID: 26478198 Free PMC article.

3

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.

Betts G, Poyntz H, Stylianou E, Reyes-Sandoval A, Cottingham M, Hill A, McShane H. Betts G, et al. PLoS One. 2012;7(12):e50447. doi: 10.1371/journal.pone.0050447. Epub 2012 Dec 21. PLoS One. 2012. PMID: 23284637 Free PMC article.

4

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice.

Griffiths KL, Stylianou E, Poyntz HC, Betts GJ, Fletcher HA, McShane H. Griffiths KL, et al. PLoS One. 2013 Oct 23;8(10):e78312. doi: 10.1371/journal.pone.0078312. eCollection 2013. PLoS One. 2013. PMID: 24194918 Free PMC article.

5

Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?

Godkin A, Ng WF, Gallagher K, Betts G, Thomas HC, Lechler RI. Godkin A, et al. Among authors: betts g. J Allergy Clin Immunol. 2008 May;121(5):1277-1284.e3. doi: 10.1016/j.jaci.2008.01.070. Epub 2008 Mar 19. J Allergy Clin Immunol. 2008. PMID: 18355912

6

Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo.

Issa F, Milward K, Goto R, Betts G, Wood KJ, Hester J. Issa F, et al. Among authors: betts g. Front Immunol. 2019 Apr 24;10:889. doi: 10.3389/fimmu.2019.00889. eCollection 2019. Front Immunol. 2019. PMID: 31068951 Free PMC article.

7

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.

Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R, Torkington J, Rees BI, Williams GT, Gallimore AM, Godkin AJ. Clarke SL, et al. PLoS One. 2006 Dec 27;1(1):e129. doi: 10.1371/journal.pone.0000129. PLoS One. 2006. PMID: 17205133 Free PMC article.

8

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.

Simon AK, Jones E, Richards H, Wright K, Betts G, Godkin A, Screaton G, Gallimore A. Simon AK, et al. Among authors: betts g. Eur J Immunol. 2007 Mar;37(3):758-67. doi: 10.1002/eji.200636593. Eur J Immunol. 2007. PMID: 17294404 Free PMC article.

9

Regulating the immune response to tumours.

Betts GJ, Clarke SL, Richards HE, Godkin AJ, Gallimore AM. Betts GJ, et al. Adv Drug Deliv Rev. 2006 Oct 1;58(8):948-61. doi: 10.1016/j.addr.2006.05.006. Epub 2006 Aug 17. Adv Drug Deliv Rev. 2006. PMID: 17070961 Review.

10

CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?

Sivasankar B, Longhi MP, Gallagher KM, Betts GJ, Morgan BP, Godkin AJ, Gallimore AM. Sivasankar B, et al. J Immunol. 2009 May 1;182(9):5203-7. doi: 10.4049/jimmunol.0804243. J Immunol. 2009. PMID: 19380765 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters